No products in the cart.
Mouse Monoclonal LSD1 antibody (STJ98515)
Supplier: St John’s Laboratory Ltd.
Recommended applications: WB, IHC, IF
Recommended dilution: WB 1:1000-1:2000; IHC 1:500-1:1000; IF 1:100-1:500
Recommended protocols: check protocols
Click or hover above images to see image description for LSD1 Monoclonal Antibody.
Check alternative names for the antibodyExpand
KDM1A antibody, AOF2 antibody, KDM1 antibody, KIAA0601 antibody, LSD1 antibody,|Amine oxidase (flavin containing) domain 2 antibody|Amine oxidase, flavin containing, 2 antibody|AOF2 antibody|BHC110 antibody|BRAF35 HDAC complex protein BHC110 antibody|BRAF35-HDAC complex protein BHC110 antibody|BRAF35/HDAC complex, 110-kD subunit antibody|CPRF antibody|EC1 antibody|FAD binding protein BRAF35 HDAC complex, 110 kDa subunit antibody|Flavin-containing amine oxidase domain-containing protein 2 antibody|KDM 1 antibody|KDM1 antibody|Kdm1a antibody|KDM1A_HUMAN antibody|KIAA0601 antibody|LSD 1 antibody|LSD1 antibody|Lysine (K) specific demethylase 1 antibody|Lysine (K) specific demethylase 1A antibody|Lysine demethylase 1A antibody|Lysine specific histone demethylase 1 antibody|Lysine specific histone demethylase 1A antibody|Lysine-specific demethylase 1 antibody|Lysine-specific demethylase 1A antibody|Lysine-specific histone demethylase 1A antibody|Anti-KDM1 / LSD1 antibody – ChIP Grade (ab17721)
SCBT cat No: sc-53875|sc-136174|sc-271720|sc-67272|sc-49294|
LSD1 Monoclonal Antibody
|Catalogue No.|| |
Human, Mouse, Cow, Dog, Pig
LSD1 Monoclonal Antibody detects endogenous levels of LSD1 protein.
Purified recombinant human LSD1 (N-terminus) protein fragments expressed in Ecoli
WB, IHC, IF
|Recommended dilution|| |
WB 1:1000-1:2000; IHC 1:500-1:1000; IF 1:100-1:500
LSD1 Antibody was tube-contained. Purified in buffer containing 0.1M Tris-Glycine (pH 7.4, 150 mM NaCl) with 0.2% sodium azide, 50% glycerol.
LSD1 Antibody was purified using affinity purification.
-20 Celsius degree. Avoid repeated freeze/thaw cycles.
|Alternative antibody names|| |
Lysine-specific histone demethylase 1A antibody, BRAF35-HDAC complex protein BHC110 antibody, Flavin-containing amine oxidase domain-containing protein 2 antibody
|Protein names|| |
Lysine-specific histone demethylase 1A , BRAF35-HDAC complex protein BHC110 , Flavin-containing amine oxidase domain-containing protein 2
|Protein function|| |
Histone demethylase that demethylates both ‘Lys-4’ (H3K4me) and ‘Lys-9’ (H3K9me) of histone H3, thereby acting as a coactivator or a corepressor, depending on the context. Acts by oxidizing the substrate by FAD to generate the corresponding imine that is subsequently hydrolyzed. Acts as a corepressor by mediating demethylation of H3K4me, a specific tag for epigenetic transcriptional activation. Demethylates both mono- (H3K4me1) and di-methylated (H3K4me2) H3K4me. May play a role in the repression of neuronal genes. Alone, it is unable to demethylate H3K4me on nucleosomes and requires the presence of RCOR1/CoREST to achieve such activity. Also acts as a coactivator of androgen receptor (ANDR)-dependent transcription, by being recruited to ANDR target genes and mediating demethylation of H3K9me, a specific tag for epigenetic transcriptional repression. The presence of PRKCB in ANDR-containing complexes, which mediates phosphorylation of ‘Thr-6’ of histone H3 (H3T6ph), a specific tag that prevents demethylation H3K4me, prevents H3K4me demethylase activity of KDM1A. Demethylates di-methylated ‘Lys-370’ of p53/TP53 which prevents interaction of p53/TP53 with TP53BP1 and represses p53/TP53-mediated transcriptional activation. Demethylates and stabilizes the DNA methylase DNMT1. Required for gastrulation during embryogenesis. Component of a RCOR/GFI/KDM1A/HDAC complex that suppresses, via histone deacetylase (HDAC) recruitment, a number of genes implicated in multilineage blood cell development. Effector of SNAI1-mediated transcription repression of E-cadherin/CDH1, CDN7 and KRT8. Required for the maintenance of the silenced state of the SNAI1 target genes E-cadherin/CDH1 and CDN7. / FAD / 3.0 µM for H3 monomethyl-K4 / 4.2 µM for H3 dimethyl-K4 / 3.9 µM for H3 monomethyl-K4-monomethyl-K9 / 17.5 µM for monomethyl-K4-acetyl-K9
|Protein tissue specificity|| |
|Involvement in disease|| |
Cleft palate, psychomotor retardation, and distinctive facial features (CPRF) [MIM:616728]: A syndrome characterized by cleft palate, developmental delay, psychomotor retardation, and facial dysmorphic features including a prominent forehead, slightly arched eyebrows, elongated palpebral fissures, a wide nasal bridge, thin lips, and widely spaced teeth. Cleft palate is a congenital fissure of the soft and/or hard palate, due to faulty fusion. . Note: The disease is caused by mutations affecting the gene represented in this entry.
|Protein sequence and domain|| |
The SWIRM domain may act as an anchor site for a histone tail. / Belongs to the flavin monoamine oxidase family. / Contains 1 SWIRM domain.
|Protein cellular localization|| |
AntibodyPlus can customize LSD1 Antibody according to your requirement, including bulk product size,etc. Please contact email@example.com. AntibodyPlus provide antibody trial sample for your own antibody validation and collects antibody reviews.
St John’s Laboratory Ltd.
|Product type|| |
There are no reviews for this product yet.
By submitting a review, get following benefits:
1. Receive $50 ABcoins as credit for each review.
2. First trial sample order will be fully refunded as credit.
3. Have a chance to win a $50 amazon gift card!
There is no extra validation for this product yet.
Check other extra validated antibodies below: